Private Equity

Amid a tough real estate market, one firm launched $2B in projects and expanded to the UK. Here’s how Landmark Properties is redefining student living.

SpecialtyRx launches a major Austin pharmacy, creating jobs and responding to Central Texas's rapid demographic shift toward an older population.

The strategic acquisition of Burns Engineering positions DwyerOmega to lead high-stakes industries by combining a broad portfolio with metrology-grade accuracy.

A strategic partnership between Broadview Group and Citadel EHS signals a major bet on the booming environmental, health, and safety compliance industry.

Singapore's Temasek injects another $150M into Roc360's REIT, highlighting a major institutional shift to real estate debt to fix America's aging houses.

A new report finds 90% of nurses miss key updates due to flawed communication, leading to patient care errors and fueling the nursing staff crisis.

Signature Aviation's new terminal at Guanacaste Airport will blend high-end travel with sustainability, boosting Costa Rica's luxury eco-tourism market.

With two key acquisitions, Currier Plastics expands its footprint and cleanroom capacity, signaling a major consolidation play by Sheridan Capital Partners.

With key studies now complete, Biofrontera's light-based therapy Ameluz could soon offer a new weapon against widespread actinic keratosis and stubborn acne.

The investment giant's new podcast season tackles the energy trilemma, exploring AI's power thirst, the return of nuclear, and fossil fuel's role.

Industry veteran Wes Champion takes the helm at VMG Health, signaling a new era of aggressive, PE-backed expansion in the complex healthcare consulting market.

A new study on oral testosterone therapy for men 65-80 could reshape geriatric care, challenge FDA guidelines, and unlock a multi-billion dollar market.

Cizzle Brands' $83.75M acquisition of Flow Water's manufacturing arm is a strategic masterstroke, creating a vertically integrated beverage powerhouse.

Collegium Pharmaceutical projects robust 2026 revenue fueled by its ADHD drug Jornay PM, savvy debt refinancing, and a proactive generic strategy.

Keystone doubles down on AI advisory with Audax Private Equity's backing, spinning off its supply chain software unit into a new powerhouse, Keystone AI.

The opioid treatment specialist projects over $1.1B in revenue, driven by its flagship drug SUBLOCADE and a major strategic overhaul in the U.S.

The medtech firm's preliminary results show a Q4 revenue uptick but miss yearly estimates, signaling a stabilizing but cautious path forward for 2026.

The special mission aviation provider completes a buyout of Bain Capital, consolidating NTC Group's ownership and securing new capital to expand its services.

With a 432% share price jump and billions in financing lined up, Troilus Gold's Quebec project is becoming a cornerstone of North America's critical minerals.

Calgary-based Horizon Petroleum faces a Management Cease Trade Order over delayed financial filings, raising questions about its European operations.